BRTX
Price
$1.55
Change
-$0.04 (-2.52%)
Updated
Jul 3 closing price
Capitalization
11.63M
45 days until earnings call
HLOSF
Price
$2.70
Change
-$0.55 (-16.92%)
Updated
Jul 1 closing price
Capitalization
299.22M
Interact to see
Advertisement

BRTX vs HLOSF

Header iconBRTX vs HLOSF Comparison
Open Charts BRTX vs HLOSFBanner chart's image
BioRestorative Therapies
Price$1.55
Change-$0.04 (-2.52%)
Volume$43.52K
Capitalization11.63M
HEALIOS K K
Price$2.70
Change-$0.55 (-16.92%)
Volume$100
Capitalization299.22M
BRTX vs HLOSF Comparison Chart in %
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. HLOSF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a StrongBuy and HLOSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BRTX: $1.55 vs. HLOSF: $2.70)
Brand notoriety: BRTX and HLOSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 34% vs. HLOSF: 53%
Market capitalization -- BRTX: $11.63M vs. HLOSF: $299.22M
BRTX [@Biotechnology] is valued at $11.63M. HLOSF’s [@Biotechnology] market capitalization is $299.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 0 FA rating(s) are green whileHLOSF’s FA Score has 0 green FA rating(s).

  • BRTX’s FA Score: 0 green, 5 red.
  • HLOSF’s FA Score: 0 green, 5 red.
According to our system of comparison, BRTX is a better buy in the long-term than HLOSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 3 TA indicator(s) are bullish while HLOSF’s TA Score has 4 bullish TA indicator(s).

  • BRTX’s TA Score: 3 bullish, 8 bearish.
  • HLOSF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, HLOSF is a better buy in the short-term than BRTX.

Price Growth

BRTX (@Biotechnology) experienced а -7.19% price change this week, while HLOSF (@Biotechnology) price change was -14.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BRTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($299M) has a higher market cap than BRTX($11.6M). HLOSF YTD gains are higher at: 100.000 vs. BRTX (8.392). BRTX has higher annual earnings (EBITDA): -12.06M vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 8.89B vs. BRTX (9.11M). BRTX has less debt than HLOSF: BRTX (42.4K) vs HLOSF (6.1B). HLOSF has higher revenues than BRTX: HLOSF (521M) vs BRTX (391K).
BRTXHLOSFBRTX / HLOSF
Capitalization11.6M299M4%
EBITDA-12.06M-2.39B1%
Gain YTD8.392100.0008%
P/E RatioN/AN/A-
Revenue391K521M0%
Total Cash9.11M8.89B0%
Total Debt42.4K6.1B0%
FUNDAMENTALS RATINGS
BRTX: Fundamental Ratings
BRTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRTXHLOSF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
33%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
25%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
30%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
31%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
24%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
67%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAM71.961.92
+2.74%
Pampa Energia SA
TRIN14.290.09
+0.63%
Trinity Capital
BOLT5.920.01
+0.17%
Bolt Biotherapeutics Inc
SHIP6.47-0.04
-0.61%
Seanergy Maritime Holdings Corp
WLK81.11-0.74
-0.90%
Westlake Corp

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with TCRT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
-2.52%
TCRT - BRTX
33%
Loosely correlated
-1.19%
ORIC - BRTX
31%
Poorly correlated
+1.41%
CERO - BRTX
29%
Poorly correlated
-2.11%
NUVL - BRTX
29%
Poorly correlated
-0.02%
GRCE - BRTX
28%
Poorly correlated
+3.64%
More

HLOSF and

Correlation & Price change

A.I.dvisor tells us that HLOSF and BRTX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLOSF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
BRTX - HLOSF
23%
Poorly correlated
-2.52%
LGVN - HLOSF
22%
Poorly correlated
N/A
ENTBF - HLOSF
7%
Poorly correlated
N/A
CPMV - HLOSF
5%
Poorly correlated
+9.02%
SLN - HLOSF
3%
Poorly correlated
-2.99%
More